Cargando…
Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers in China and frequently occurs with chronic hepatitis B virus infection. To investigate whether cell-based cancer immunotherapy induces tumor specific immune responses in patients with HCC and provides clinical benefits, as...
Autores principales: | Han, Yanyan, Wu, Yeting, Yang, Chou, Huang, Jing, Guo, Yabing, Liu, Li, Chen, Ping, Wu, Dongyun, Liu, Junyun, Li, Jin, Zhou, Xiangjun, Hou, Jinlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363021/ https://www.ncbi.nlm.nih.gov/pubmed/28330473 http://dx.doi.org/10.1186/s12967-017-1165-0 |
Ejemplares similares
-
Cancer immunotherapy with multiple tumor antigen activated autologous T cells in patients with HBV related hepatocellular carcinoma
por: Han, Yanyan, et al.
Publicado: (2014) -
Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study
por: He, Yajing, et al.
Publicado: (2018) -
Immunotherapy with patient-specific antigens selection reduced the metastasis of a cervical cancer patient
por: Han, Yanyan, et al.
Publicado: (2015) -
A Plant-Produced Antigen Elicits Potent Immune Responses against West Nile Virus in Mice
por: He, Junyun, et al.
Publicado: (2014) -
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients
por: Dong, X-Y, et al.
Publicado: (2003)